DA Davidson Research Analysts Increase Earnings Estimates for USANA Health Sciences, Inc. (NYSE:USNA)

USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Research analysts at DA Davidson upped their FY2024 earnings estimates for USANA Health Sciences in a note issued to investors on Tuesday, May 7th. DA Davidson analyst L. Weiser now forecasts that the company will post earnings of $2.75 per share for the year, up from their prior estimate of $2.70. DA Davidson currently has a "Neutral" rating and a $46.00 price objective on the stock. The consensus estimate for USANA Health Sciences' current full-year earnings is $2.75 per share. DA Davidson also issued estimates for USANA Health Sciences' FY2025 earnings at $2.90 EPS.

USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.35. The firm had revenue of $221.08 million for the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%.

Separately, StockNews.com raised shares of USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a research note on Friday, January 12th.

USANA Health Sciences Stock Up 2.9 %

Shares of USNA traded up $1.30 during trading hours on Thursday, hitting $46.32. The company had a trading volume of 71,519 shares, compared to its average volume of 81,320. USANA Health Sciences has a 12 month low of $41.45 and a 12 month high of $69.60. The firm has a market cap of $889.34 million, a price-to-earnings ratio of 14.43, a PEG ratio of 1.38 and a beta of 0.94. The business has a fifty day moving average of $46.42 and a 200-day moving average of $48.05.

Insider Activity at USANA Health Sciences

In related news, insider Daniel A. Macuga sold 3,791 shares of the business's stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total value of $178,707.74. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, CFO G Doug Iiekking sold 5,198 shares of the business's stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total transaction of $232,662.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Daniel A. Macuga sold 3,791 shares of the business's stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total value of $178,707.74. The disclosure for this sale can be found here. In the last three months, insiders have sold 34,286 shares of company stock worth $1,634,010. Company insiders own 0.33% of the company's stock.

Institutional Trading of USANA Health Sciences

Hedge funds have recently bought and sold shares of the company. CWM LLC lifted its position in USANA Health Sciences by 21.8% in the first quarter. CWM LLC now owns 1,543 shares of the company's stock valued at $75,000 after purchasing an additional 276 shares during the last quarter. New York State Common Retirement Fund lifted its position in USANA Health Sciences by 1.2% in the fourth quarter. New York State Common Retirement Fund now owns 24,500 shares of the company's stock valued at $1,313,000 after purchasing an additional 279 shares during the last quarter. Swiss National Bank lifted its position in USANA Health Sciences by 1.2% in the third quarter. Swiss National Bank now owns 25,500 shares of the company's stock valued at $1,495,000 after purchasing an additional 300 shares during the last quarter. Rhumbline Advisers raised its holdings in shares of USANA Health Sciences by 1.4% during the third quarter. Rhumbline Advisers now owns 34,942 shares of the company's stock valued at $2,048,000 after acquiring an additional 496 shares in the last quarter. Finally, Strs Ohio raised its holdings in shares of USANA Health Sciences by 4.8% during the third quarter. Strs Ohio now owns 10,900 shares of the company's stock valued at $638,000 after acquiring an additional 500 shares in the last quarter. Institutional investors own 54.25% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.